1.90
price down icon1.55%   -0.03
 
loading

Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
20.03%
0.869
0.724 0.893 0.784 0.952
Operating Expenses
16.45%
1.685
1.447 2.445 1.646 1.647
Depreciation and Amortization
1.06%
0.095
0.094 0.097 0.096 0.096
Operating Income/Loss
12.86%
-0.816
-0.723 -1.552 -0.862 -0.695
Nonoperating Income/Loss
18.64%
0.98
0.826 0.972 0.912 1.24
Income/Loss From Continuing Operations Before Tax
59.22%
0.164
0.103 -0.58 0.05 0.545
Income/Loss From Continuing Operations After Tax
59.22%
0.164
0.103 -0.612 0.05 0.545
Income/Loss From Discontinued Operations, Net Of Tax
12.50%
-0.009
-0.008 -0.007 0.102 0.006
Net Income/Loss
63.16%
0.155
0.095 -0.619 0.152 0.551
Basic Average Shares
99,900%
11.57
0.0116 - 11.57 11.57
Diluted Average Shares
99,926%
11.64
0.0116 - 11.57 11.57
Basic Earnings Per Share
0.00%
0.01
0.01 - 0.01 0.05
Diluted Earnings Per Share
0.00%
0.01
0.01 - 0.01 0.05
$2.04
price up icon 1.49%
$5.08
price down icon 8.80%
UPC UPC
$3.93
price down icon 5.30%
$3.38
price up icon 5.96%
$7.43
price down icon 6.89%
$0.7099
price down icon 2.47%
Kapitalisierung:     |  Volumen (24h):